{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:59:55Z","timestamp":1790373595860,"version":"4.1.0"},"reference-count":106,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Endocrino Diabet &amp; Metabol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiometabolic disorders such as type 2 diabetes mellitus (T2DM), obesity and cardiovascular disease (CVD) remain major global health challenges. Incretin\u2010based therapies, including the GLP\u20101 receptor agonists semaglutide and liraglutide, and the dual GIP\/GLP\u20101 receptor agonist tirzepatide, are increasingly used to address hyperglycaemia and obesity, and have been evaluated for both cardiometabolic risk markers and selected cardiovascular and renal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review summarizes and contrasts the pharmacology of semaglutide, liraglutide and tirzepatide, distinguishing between surrogate cardiometabolic risk markers (e.g., glycaemic control, body weight and lipid parameters) and confirmed clinical outcomes, including major adverse cardiovascular events (MACE) and renal endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Recent data were synthesized from pivotal randomized clinical trial programs, SUSTAIN and PIONEER (semaglutide), LEADER (liraglutide) and SURPASS and SURMOUNT (tirzepatide), as well as meta\u2010analyses, post hoc analyses and observational studies addressing mechanistic and long\u2010term cardiometabolic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All three agents improved HbA1c, weight and cardiometabolic outcomes, with tirzepatide generally showing greater reductions across clinical trials. Semaglutide and liraglutide consistently improved BMI, lipid profile and cardiovascular risk, while tirzepatide shows promise pending CVOT data. Renal outcomes were favourable across the class, though results varied by baseline characteristics and trial design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Semaglutide, liraglutide and tirzepatide are key therapies for type 2 diabetes and cardiometabolic disease. Tirzepatide's dual activity may enhance metabolic and lipid outcomes, while semaglutide and liraglutide have strong evidence for cardiovascular and renal safety. However, comparisons are based on indirect evidence and should be interpreted cautiously.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/edm2.70338","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:57:35Z","timestamp":1789559855000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-5646","authenticated-orcid":false,"given":"Hiba","family":"Bawadi","sequence":"first","affiliation":[{"name":"Department of Human Nutrition College of Health Sciences, QU\u2010HEALTH, Qatar University  Doha Qatar"},{"name":"Clinical Affairs Department QU\u2010HEALTH, Qatar University  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6643-3655","authenticated-orcid":false,"given":"Haya","family":"Abuhijleh","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition College of Health Sciences, QU\u2010HEALTH, Qatar University  Doha Qatar"},{"name":"Department of Biomedical Sciences College of Health Sciences, QU\u2010HEALTH, Qatar University  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8984-0360","authenticated-orcid":false,"given":"Mamon","family":"Nofal","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust  Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-8367","authenticated-orcid":false,"given":"Zain Z.","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Clinical Affairs Department QU\u2010HEALTH, Qatar University  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-4001","authenticated-orcid":false,"given":"Maha","family":"Al\u2010Asmakh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences College of Health Sciences, QU\u2010HEALTH, Qatar University  Doha Qatar"},{"name":"Biomedical Research Center QU\u2010HEALTH, Qatar University  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2021.784731"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202005828"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.03.012"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21107"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2025.03.008"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.12.001"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12808"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616011"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017860"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1398059"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28683-0"},{"key":"e_1_2_13_14_1","unstructured":"A.O.L.C. (Reviewer) \u201cClinical Pharmacology and Biopharmaceutics Review(s): Rybelsus (Semaglutide): NDA 213051 \u201dhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/213051Orig1s000MedR.pdf."},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09735-8"},{"key":"e_1_2_13_16_1","volume-title":"StatPearls","author":"Kommu S.","year":"2024"},{"key":"e_1_2_13_17_1","volume-title":"Rybelsus (Semaglutide)\u2014Assessment Report","author":"(EMA), E.M.A","year":"2020"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107519"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-025-00245-5"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01053-7"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916038"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v10.i1.1"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13120"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0524-z"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-2366"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110605"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2025.03.010"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00070"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30013-X"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30092-X"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0417"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30085-2"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0749"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2942"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31271-1"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02677-w"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60659-0"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61246-5"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1355"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1472-y"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2124"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0180-0"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1580159"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.36.3.358"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1715800"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0432-2"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-017-0241-z"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17010207"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01660-0"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16337"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02188-7"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14943"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14100991"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113878"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01398-1"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.21763\/tjfmpc.527970"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02996-7"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S374741"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2016.03.004"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258545"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04408-4"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3224"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2021-001952"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23808"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/11795514231213568"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15386"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01323.x"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-109"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1201977"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-025-00219-7"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-107"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8961"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01324-6"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad495"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15333"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15140"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24945"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01673.x"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0444"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1700894"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01534-5"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14952"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00070-5"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314631"},{"issue":"7","key":"e_1_2_13_85_1","article-title":"Tirzepatide Versus Semaglutide Once Weekly in Type 2 Diabetes","volume":"386","author":"Santulli G.","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052961"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.14740\/cr1441"},{"issue":"5","key":"e_1_2_13_88_1","article-title":"Effects of Once\u2010Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction\u2010Associated Steatotic Liver Disease in Japanese Patients With Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real\u2010World Data","volume":"12","author":"Katsuyama H.","year":"2024","journal-title":"Biomedicine"},{"issue":"4","key":"e_1_2_13_89_1","first-page":"171","article-title":"The Effect of Semaglutide on Glycolipid Metabolism in Type 2 Diabetes Mellitus and Non\u2010Alcoholic Fatty Liver Disease","volume":"84","author":"Li D.","year":"2022","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13120"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-10-20"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S97383"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.4236\/jdm.2023.131005"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0945-7"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.133"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12133"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14174"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01198-4"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1277113"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.7570\/jomes24008"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaf014"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00243-1"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02828-z"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01312-4"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae296"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/edm2.70338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/edm2.70338","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/edm2.70338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:11:15Z","timestamp":1790370675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/edm2.70338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/edm2.70338"],"URL":"https:\/\/doi.org\/10.1002\/edm2.70338","archive":["Portico"],"relation":{},"ISSN":["2398-9238","2398-9238"],"issn-type":[{"value":"2398-9238","type":"print"},{"value":"2398-9238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70338"}}